Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to 0.14%.

  • Nephros' Return on Capital Employed rose 2400.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 0.0% for FY2024, which is 1700.0% up from last year.
  • According to the latest figures from Q3 2025, Nephros' Return on Capital Employed is 0.14%, which was up 2400.0% from 0.13% recorded in Q2 2025.
  • Nephros' 5-year Return on Capital Employed high stood at 0.14% for Q3 2025, and its period low was 0.44% during Q4 2022.
  • Its 5-year average for Return on Capital Employed is 0.18%, with a median of 0.23% in 2021.
  • As far as peak fluctuations go, Nephros' Return on Capital Employed tumbled by -2100bps in 2022, and later soared by 2800bps in 2025.
  • Nephros' Return on Capital Employed (Quarter) stood at 0.24% in 2021, then tumbled by -86bps to 0.44% in 2022, then skyrocketed by 61bps to 0.17% in 2023, then skyrocketed by 100bps to 0.0% in 2024, then surged by 21542bps to 0.14% in 2025.
  • Its Return on Capital Employed was 0.14% in Q3 2025, compared to 0.13% in Q2 2025 and 0.08% in Q1 2025.